Founded by celebrated technologist and entrepreneur, Dr Mike Lynch OBE FREng FRS, Invoke Capital founds, invests in and advises fast-growing fundamental technology companies in Europe. With deep expertise in identifying and commercialising artificial intelligence research and a close relationship with the University of Cambridge, Invoke exists to realise the commercial possibilities of Britain’s extraordinary science and deep technology base. Since 2012, Invoke has been instrumental in founding, creating and developing prominent technologies, and then finding the right teams to scale them into global businesses. Invoke’s companies include Darktrace, a world-leading cyber AI company that employs more than 1,500 people globally, Luminance, an award-winning machine learning platform for the legal industry, and AI fraud-detection engine, Featurespace. Invoke exited data-driven medicine experts, Sophia Genetics, in 2020.